Cullinan Oncology Forms Strategic Collaboration Agreement with Mount Sinai to Advance Oral HPK1 Protein Degrader for Cancer Treatment
January 10, 2022 06:30 ET
|
Cullinan Oncology, Inc.
Collaboration to identify and advance best-in-class HPK1 protein degraders Exclusive option for Cullinan to license related intellectual property from the collaboration CAMBRIDGE, Mass., Jan. ...
LymeMIND, a division of the Icahn School of Medicine at Mount Sinai, to Host LymeMIND 2020 Virtual Conference on October 10
September 09, 2020 09:00 ET
|
LymeMIND
NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- LymeMIND, the data coordination center of the Cohen Lyme & Tickborne Disease Initiative, housed at the Icahn School of Medicine at Mount Sinai, today...
Institute for Next Generation Healthcare (INGH) at the Icahn School of Medicine at Mount Sinai Announces Upcoming LymeMIND Conference: Lyme Disease in the Era of Precision Medicine
September 18, 2019 08:15 ET
|
Institute for Next Generation Healthcare
NEW YORK, Sept. 18, 2019 (GLOBE NEWSWIRE) -- The Institute for Next Generation Healthcare (INGH) at the Icahn School of Medicine at Mount Sinai today announced that it will be hosting its fourth...
New York City Ichan School of Medicine at Mount Sinai and Renowned Global Researcher Dr. Hurd, Select MediPharm Labs to Support 500 Patient Major Clinical Study and “CBD International Consortium” to Develop Treatment of Opioid Addiction
May 22, 2019 09:08 ET
|
MediPharm Labs Corp.
TORONTO, May 22, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs”) a leader in specialized, research-driven cannabis extraction and cannabinoid...
The Institute for Next Generation Healthcare Opens Lyme Disease Experience Booth to the Public at Mount Sinai Hospital
May 13, 2019 12:14 ET
|
Institute for Next Generation Healthcare
The fully-immersive booth will be available to former and existing Lyme disease patients, caregivers, researchers, and clinicians for three weeks, providing a platform to share their stories during...
Mount Sinai Joins Test Validation Trial of bioAffinity’s CyPath® Lung
September 18, 2018 14:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced that the Icahn School of Medicine at Mount Sinai (ISMMS) in New York, NY,...
Institute for Next Generation Healthcare (INGH) at the Icahn School of Medicine at Mount Sinai Announces Upcoming LymeMIND Conference on Lyme Disease and Precision Medicine
September 04, 2018 08:00 ET
|
Institute for Next Generation Healthcare
NEW YORK, Sept. 04, 2018 (GLOBE NEWSWIRE) -- The Institute for Next Generation Healthcare (INGH) at the Icahn School of Medicine at Mount Sinai today announced that it will be hosting its third...
Renowned Cardiologist Dr. Rony Shimony Joins Biotricity Board of Advisors
November 01, 2016 08:00 ET
|
biotricity
REDWOOD CITY, Calif., Nov. 01, 2016 (GLOBE NEWSWIRE) -- biotricity, Inc. (OTCQB:BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote...